Terms: = Germ cell tumor AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Prognosis
9 results:
1. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
[TBL] [Abstract] [Full Text] [Related]
2. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
3. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemically Detected Expression of ATRX, tsc2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine tumors.
Uemura J; Okano K; Oshima M; Suto H; Ando Y; Kumamoto K; Kadota K; Ichihara S; Kokudo Y; Maeba T; Nanno Y; Toyama H; Takada Y; Shimada M; Hanazaki K; Masaki T; Suzuki Y
Ann Surg; 2021 Dec; 274(6):e949-e956. PubMed ID: 31599805
[TBL] [Abstract] [Full Text] [Related]
5. Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor.
Williamson LM; Steel M; Grewal JK; Thibodeau ML; Zhao EY; Loree JM; Yang KC; Gorski SM; Mungall AJ; Mungall KL; Moore RA; Marra MA; Laskin J; Renouf DJ; Schaeffer DF; Jones SJM
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160355
[TBL] [Abstract] [Full Text] [Related]
6. Treatment of malignant gliomas with ketogenic or caloric restricted diets: A systematic review of preclinical and early clinical studies.
Noorlag L; De Vos FY; Kok A; Broekman MLD; Seute T; Robe PA; Snijders TJ
Clin Nutr; 2019 Oct; 38(5):1986-1994. PubMed ID: 30473444
[TBL] [Abstract] [Full Text] [Related]
7. Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine tumors and Reduced Patient Survival Times.
Roy S; LaFramboise WA; Liu TC; Cao D; Luvison A; Miller C; Lyons MA; O'Sullivan RJ; Zureikat AH; Hogg ME; Tsung A; Lee KK; Bahary N; Brand RE; Chennat JS; Fasanella KE; McGrath K; Nikiforova MN; Papachristou GI; Slivka A; Zeh HJ; Singhi AD
Gastroenterology; 2018 Jun; 154(8):2060-2063.e8. PubMed ID: 29486199
[TBL] [Abstract] [Full Text] [Related]
8. Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of tsc2.
Lopez-Rivera E; Jayaraman P; Parikh F; Davies MA; Ekmekcioglu S; Izadmehr S; Milton DR; Chipuk JE; Grimm EA; Estrada Y; Aguirre-Ghiso J; Sikora AG
Cancer Res; 2014 Feb; 74(4):1067-78. PubMed ID: 24398473
[TBL] [Abstract] [Full Text] [Related]
9. [Genetics and brain gliomas].
Alentorn A; Labussière M; Sanson M; Delattre JY; Hoang-Xuan K; Idbaih A
Presse Med; 2013 May; 42(5):806-13. PubMed ID: 22789312
[TBL] [Abstract] [Full Text] [Related]
